TESTI, ROBERTO
 Distribuzione geografica
Continente #
NA - Nord America 19.379
AS - Asia 1.776
EU - Europa 1.720
SA - Sud America 255
AF - Africa 28
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 6
Totale 23.170
Nazione #
US - Stati Uniti d'America 19.320
SG - Singapore 930
CN - Cina 370
DE - Germania 306
RU - Federazione Russa 282
UA - Ucraina 239
IT - Italia 235
BR - Brasile 215
IE - Irlanda 158
VN - Vietnam 136
GB - Regno Unito 123
HK - Hong Kong 108
FI - Finlandia 107
SE - Svezia 80
FR - Francia 58
KR - Corea 54
JP - Giappone 48
CA - Canada 35
PL - Polonia 33
IN - India 28
BE - Belgio 26
BD - Bangladesh 22
NL - Olanda 22
MX - Messico 17
AR - Argentina 12
IQ - Iraq 12
CZ - Repubblica Ceca 11
KG - Kirghizistan 11
ID - Indonesia 10
ZA - Sudafrica 9
AT - Austria 8
LT - Lituania 8
EC - Ecuador 7
CL - Cile 6
PY - Paraguay 6
TR - Turchia 6
CO - Colombia 5
EU - Europa 5
PK - Pakistan 5
TN - Tunisia 5
UZ - Uzbekistan 5
AU - Australia 4
ES - Italia 4
IL - Israele 4
SA - Arabia Saudita 4
AE - Emirati Arabi Uniti 3
DZ - Algeria 3
GR - Grecia 3
KZ - Kazakistan 3
NO - Norvegia 3
NP - Nepal 3
PH - Filippine 3
BG - Bulgaria 2
EG - Egitto 2
GA - Gabon 2
IR - Iran 2
KE - Kenya 2
LY - Libia 2
MY - Malesia 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PE - Perù 2
PT - Portogallo 2
RO - Romania 2
RS - Serbia 2
TH - Thailandia 2
VE - Venezuela 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BW - Botswana 1
BZ - Belize 1
CG - Congo 1
CH - Svizzera 1
CR - Costa Rica 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GE - Georgia 1
JO - Giordania 1
LV - Lettonia 1
MQ - Martinica 1
MT - Malta 1
NG - Nigeria 1
QA - Qatar 1
Totale 23.170
Città #
Woodbridge 5.305
Wilmington 4.827
Houston 4.312
Fairfield 612
Ann Arbor 558
Singapore 452
Chandler 443
Ashburn 396
Seattle 246
Jacksonville 225
San Jose 221
Cambridge 194
Dearborn 145
New York 143
Dublin 141
Rome 124
Medford 119
Beijing 117
Hong Kong 106
The Dalles 71
Los Angeles 67
Santa Clara 61
Council Bluffs 59
Munich 58
Lawrence 56
Chicago 45
Tokyo 45
Dallas 42
Guangzhou 42
Mülheim 42
Ho Chi Minh City 41
Helsinki 36
Moscow 36
Buffalo 35
Menlo Park 33
Hanoi 30
São Paulo 29
Milan 28
Brussels 26
Turku 21
San Diego 19
Boardman 16
London 16
Orem 16
Palo Alto 16
Warsaw 16
Chennai 15
Falls Church 15
Mountain View 15
Nuremberg 15
Lauterbourg 14
Brooklyn 13
Atlanta 12
Denver 12
Hefei 12
Kraków 12
Redwood City 12
Montreal 11
Amsterdam 10
Frankfurt am Main 10
San Mateo 10
Brno 9
Kunming 9
Norwalk 9
Poplar 9
Toronto 9
Nanjing 8
Salt Lake City 8
Stockholm 8
University Park 8
Belo Horizonte 7
Haiphong 7
Redondo Beach 7
Rio de Janeiro 7
San Francisco 7
Shenyang 7
Vienna 7
Da Nang 6
Elk Grove Village 6
Johannesburg 6
Manchester 6
Nanchang 6
Querétaro 6
Wuhan 6
Calgary 5
Columbus 5
Curitiba 5
Detroit 5
Jinan 5
Mexico City 5
Miami 5
Saint Petersburg 5
Tampa 5
Tashkent 5
Ankara 4
Asunción 4
Brasília 4
Hangzhou 4
Jakarta 4
New Delhi 4
Totale 20.118
Nome #
Silencing of SH-PTP2 defines a crucial role in the inactivation of epidermal growth factor receptor by 5-aminosalicylic acid in colon cancer cells 607
E3 Ligase RNF126 Directly Ubiquitinates Frataxin, Promoting Its Degradation: Identification of a Potential Therapeutic Target for Friedreich Ataxia 531
Analysis of intracellular distribution and apoptosis involvement of the Ufd1l gene product by over-expression studies 506
5-aminosalicylic acid enhances anchorage-independent colorectal cancer cell death 497
A caspaselike activity is triggered by LPS and is required for survival of human dendritic cells 494
GD3 ganglioside directly targets mitochondria in a bcl-2-controlled fashion 492
Preventing the ubiquitin-proteasome-dependent degradation of frataxin, the protein defective in Friedreich's ataxia 490
Molecular control of the cytosolic aconitase/IRP1 switch by extramitochondrial frataxin 487
C. elegans as a model for Friedreich Ataxia 484
Highly specific ubiquitin-competing molecules effectively promote frataxin accumulation and partially rescue the aconitase defect in Friedreich ataxia cells 483
Disialoganglioside GD3 is released by microglia and induces oligodendrocyte apoptosis 478
GD3 ganglioside as an intracellular mediator of apoptosis 474
A pool of extramitochondrial frataxin that promotes cell survival 473
c-Abl acetylation by histone acetyltransferases regulates its nuclear-cytoplasmic localization 472
Src kinase phosphorylates Caspase-8 on Tyr380: a novel mechanism of apoptosis suppression 467
Caspase-dependent cleavage of c-Abl contributes to apoptosis 465
Primary macrophages infected by human immunodeficiency virus trigger CD95-mediated apoptosis of uninfected astrocytes 461
Calnexin suppresses GD3 synthase-induced apoptosis 459
Frataxin participates to the hypoxia-induced response in tumors 454
Autophagy induction extends lifespan and reduces lipid content in response to frataxin silencing in C. elegans 448
Differential regulation of apoptotic cell death in senescent human cells 446
A role for p53 in mitochondrial stress response control of longevity in C. elegans. 446
Acetylation suppresses the proapoptotic activity of GD3 ganglioside 444
Long-lived C. elegans Mitochondrial mutants as a model for human mitochondrial-associated diseases 443
TRANSCRIPTIONAL REGULATION OF INTERLEUKIN-2 GENE-EXPRESSION BY CD69-GENERATED SIGNALS 443
Mitochondrial lipids as apoptosis regulators 442
UVB-induced apoptosis of human dendritic cells: contribution by caspase-dependent and caspase-independent pathways 442
Intracellular mediators of programmed cell death initiated at the cell surface receptor Fas 441
9-O-acetyl GD3 protects tumor cells from apoptosis 438
GD3 in cellular ageing and apoptosis 436
Mitochondria as sensors of sphingolipids 435
Differential regulation of apoptotic cell death in senescent human cells 434
Lipid signaling in CD95-mediated apoptosis 433
Ceramide catabolism critically controls survival of human dendritic cells 422
Lipid and glycolipid mediators in CD95-induced apoptotic signaling. 421
In vivo maturation of human frataxin 419
Is it cytotoxicity or apoptosis which causes cell death in autoimmunity? 418
p53/CEP-1 increases or decreases lifespan, depending on level of mitochondrial bioenergetic stress 416
Reduced expression of frataxin extends the lifespan of Caenorhabditis elegans 403
GD3 ganglioside and apoptosis 401
p21(Waf1/Cip1/Sdi1) mediates shear stress-dependent antiapoptotic function 400
Src inhibitors modulate frataxin protein levels 393
The ganglioside GD3 as the greek goddess Hecate: Several faces turned towards as many directions 383
Requirement for GD3 ganglioside in CD95- and ceramide-induced apoptosis 382
Lipopolysaccharide induces jun N-terminal kinase activation in macrophages by a novel Cdc42/Rac-independent pathway involving sequential activation of protein kinase C zeta and phosphatidylcholine-dependent phospholipase C 373
ATM Kinase activity modulates Fas sensitivity through the regulation of FLIP in lymphoid cells 365
Interferon gamma upregulates frataxin and corrects the functional deficits in a Friedreich ataxia model 339
Frataxin deficiency in Friedreich’s ataxia is associated with reduced levels of HAX-1, a regulator of cardiomyocyte death and survival 321
Drug repositioning screening identifies etravirine as a potential therapeutic for friedreich's ataxia 310
Biophysical characterisation of the recombinant human frataxin precursor 303
SINEUP non-coding RNAs rescue defective frataxin expression and activity in a cellular model of Friedreich's Ataxia 240
Analyzing the effects of a G137V mutation in the FXN gene 221
An RNA-seq study in Friedreich ataxia patients identified hsa-miR-148a-3p as a putative prognostic biomarker of the disease 208
GIFT-1, a phase IIa clinical trial to test the safety and efficacy of IFNγ administration in FRDA patients 191
Hsa-miR223-3p circulating level is upregulated in Friedreich's ataxia and inversely associated with HCLS1 associated protein X-1, HAX-1 116
Safety and efficacy of interferon γ in friedreich's ataxia 108
Interferon gamma enhances cytoprotective pathways via Nrf2 and MnSOD induction in Friedreich’s ataxia cells 87
Drug Repositioning in Friedreich Ataxia 79
Sensitivity of neuroimaging indicators in monitoring the effects of interferon gamma treatment in Friedreich's Ataxia 78
A Pilot Phase 2 Randomized Trial to Evaluate the Safety and Potential Efficacy of Etravirine in Friedreich Ataxia Patients 37
Lipid signaling in CD95-mediated apoptosis 23
Totale 23.302
Categoria #
all - tutte 49.926
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.926


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021170 0 0 0 0 0 0 0 0 0 0 120 50
2021/2022586 15 26 22 24 32 97 16 21 56 67 18 192
2022/2023917 105 100 80 124 72 164 44 52 89 7 60 20
2023/2024303 41 10 10 5 24 116 11 14 3 4 12 53
2024/20251.449 102 291 130 72 53 63 60 100 130 125 170 153
2025/20262.323 183 133 249 326 299 79 273 314 240 206 21 0
Totale 23.302